Unit 4 - Heart Failure Flashcards

1
Q

what is the definition of CHF?

A

inability of heart to pump blood at rate commensurate w/ requirements of metabolizing tissues, or can only do so from elevated filling pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the definition of heart failure? main clinical manifestations? what is it usually from?

A

syndrome from any structural or functional disorder that impairs ability of ventricle to fill or eject blood

  • dyspnea, fatigue, fluid retention (central or peripheral)
  • may result from normal LV size and function to sever dilation and systolic dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the NY heart association functional classifications for HF?

A

I: cardiac disease w/o limitations on PA (SOB only if extreme)
II: slight limitation of PA (SOB if climb many stairs)
III: marked limitation of PA (SOB if walk to kitchen)
IV: inability to carry any PA (SOB even at rest)
-end-stage, poorest outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why are HF patients unable to exercise?

A

cardiac function:

  • alternations in ventricular distensibility
  • valvular regurgitation
  • pericardial restraint
  • cardiac rhythm
  • conduction abnormalities
  • RV function

non-cardiac:

  • peripheral vascular function
  • skeletal muscle physiology
  • pulmonary dynamics
  • neurohormonal and reflex autonomic activity
  • renal Na handling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

explain the progression of HF?

A

LV dysfunction begins with injury to myocardium –> change in LV geometry and structure (cardiac remodeling)
-activation of endogenous neurohormonal systems play major role in this remodeling, thus want to interrupt this cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the neurohormonal impact in HF patients?

A

elevated levels of NE, AII, aldosterone, endothelin, ADH, and cytokines, that adversely affect structure and function of heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are compensatory mech in HF in ANS?

A

heart: increased HR, myocardial contractile stimulation (inotropy), relaxation (chronotropy)
peripheral circulation: arterial and venous vasoconstriction (increased afterload and preload, respectively)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are compensatory mech in HF in kidney?

A

due to RAAS

  • arterial and venous vasoconstriction (increased afterload and preload, respectively)
  • Na and water retention (increased preload and afterload)
  • increased myocardial contractile stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are compensatory mech in HF in heart?

A
  • endothelin 1 (increased preload and afterload)
  • ADH (increased preload and afterload)
  • natriuretic peptides (decreased afterload)
  • prostaglandins
  • Frank-Starling law (increased EDV/preload, EDP)
  • hypertrophy
  • peripheral O2 delivery
  • -redistribution of CO, altered O2-Hb dissociation, increased O2 extraction by tissues
  • anaerobic metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACEi hemodynamic effects?

A
  • arteriovenous vasodilation
  • -decrease PCWP and LVEDP
  • -decrease SVR and BP
  • -increase CO and exercise tolerance
  • no change in HR/contractility
  • decreased MVO2
  • increased renal, coronary, and cerebral flow
  • diuresis and natriuresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are advantages of ACEi?

A
  • inhibit LV remodeling post-MI
  • modify progression of chronic CHF
  • -increase survival
  • -decrease hospitalizations
  • -improve QOL
  • no neurohormonal activation or reflex tachycardia
  • tolerance doesn’t develop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are indications for ARBs?

A
  • used in place of ACEi when cough an issue
  • -still causes angioedema
  • used in tandem with ACEi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ASE of ARBs?

A

fewer than ACEi

  • deccreases GFR
  • raises K+
  • hypotension
  • angioedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why do we only use diuretics to treat HF symptoms?

A
  • neurohormonal activation (increases levels of NE and AII)
  • contraindicated in hypovolemia
  • ASE: volume contraction and electrolyte depletion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what do diuretics do to CO? arteries?

A

no direct effect on CO (unless excessive preload reduction), but improves arterial distensibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why are aldosterone antagonists good for HF?

A

the risk of death is reduced in class IV patients

17
Q

what is eplerenone?

A

an aldosterone antagonist that doesn’t cause gynocomasetia

18
Q

side effects of aldosterone

A
  • hyperkalemia
  • metabolic acidosis
  • gynecomastia
  • gastric disturbances (peptic ulcer)
19
Q

how should you use beta-blockers?

A

initiate at very low dose, and gradually increased if tolerated

  • will initially increase CO, but will peter out
  • can be initiated even if hospitalized for HF, as long as IV therapy for HF not required
20
Q

what is digoxin? how does it work?

A

cardiac glycoside; potent inhibitor of cellular Na+/K+ ATPase

  • increases intracellular Na+ –> Na+/Ca++ exchange system increases –> intracellular Ca++ increases –> increases contractility
  • increases vagal efferent activity to heart
  • reduces sinoatrial firing rate
  • reduces conduction velocity thru AV node
21
Q

what are hemodynamic effects of digoxin?

A
  • increase CO, LVEF, exercise tolerance, natriuresis

- decrease LVEDP, neurohormonal activation

22
Q

what are neurohormonal effects of digoxin?

A
  • increased vagal tone
  • decreased plasma NE, peripheral NS activity, RAAS activity
  • normalizes arterial baroreceptors
23
Q

why isn’t digoxin used all the time?

A

management issue: narrow therapeutic/toxic window can cause easy overdose

  • toxicity: cardiac arrythmias (commonly atrial tachycardia and AV block)
  • not given to end-stage disease
24
Q

how is digoxin metabolized?

A

kidneys

25
Q

how is dobutamine given?

A

given as continuous infusion

  • short onset of action and half-life
  • can develop tolerance after 24 to 48 hours of same dose
  • acutely improves symptoms, but increases mortality overall
26
Q

what is milrinone?

A

phosphodiesterase IIIa inhibitor

-causes less breakdown of cAMP, so increased contractility (inotropy), HR (chronotropy), and relaxation (lusitropy)

27
Q

how is milrinone given?

A

continuous infusion, and must be adjusted for renal function

  • no demonstrated tolerance development, but for short term (48 to 72 hours)
  • no difference in hospital stay, but increased hypotensive events, atrial arrhythmias, and overall mortality